# Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy

> **NCT04468867** · NA · UNKNOWN · sponsor: **The Leeds Teaching Hospitals NHS Trust** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Automated whole breast ultrasound
- **DIAGNOSTIC_TEST:** Breast MRI

## Key facts

- **NCT ID:** NCT04468867
- **Lead sponsor:** The Leeds Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-22
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468867, "Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04468867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*